Literature DB >> 3262757

Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup.

W Mau1, H Zeidler, R Mau, A Majewski, J Freyschmidt, W Stangel, H Deicher.   

Abstract

Eighty-eight patients with possible ankylosing spondylitis (AS) were selected for this followup study. They showed normal or at most suspicious radiographic findings of the sacroiliac joints. After 5 years' followup, 24, and after 10 years 32 patients (59% of the 54 finally available, 36% of the 88 original patients) had definite AS. In 12 individuals, AS could be excluded. Of the 10 remaining patients, 6 still had possible, and 4 had undifferentiated spondyloarthropathy. A comparison between HLA-B27 positive and negative patients showed a significantly increased frequency of definite AS or possible and undifferentiated spondyloarthropathy (p less than 0.05) in the group of HLA-B27 positive patients. The development of AS was characterized by a prolonged course: radiological sacroiliitis became evident after at least 9 +/- 6 years, radiological signs of spinal involvement after 11 +/- 6 years mean disease duration. After 18 +/- 6 years 25 (78%) of 32 patients with AS still maintained good or sufficient functional capacity, indicating a good functional prognosis in the great majority of the patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262757

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  93 in total

Review 1.  Ankylosing spondylitis: introductory comments on its diagnosis and treatment.

Authors:  M A Khan
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

2.  Value of diffusion-weighted magnetic resonance imaging in early diagnosis of ankylosing spondylitis.

Authors:  Fei Ai; Tao Ai; Xiaoming Li; Daoyu Hu; Wei Zhang; John N Morelli
Journal:  Rheumatol Int       Date:  2012-01-03       Impact factor: 2.631

Review 3.  Axial spondyloarthritis: concept, construct, classification and implications for therapy.

Authors:  Philip C Robinson; Sjef van der Linden; Muhammad A Khan; William J Taylor
Journal:  Nat Rev Rheumatol       Date:  2020-12-23       Impact factor: 20.543

Review 4.  Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.

Authors:  J Sieper; M Rudwaleit
Journal:  Ann Rheum Dis       Date:  2004-11-04       Impact factor: 19.103

5.  Sulfasalazine in undifferentiated spondyloarthropathies.

Authors:  Mazen Elyan; Muhammad Asim Khan
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

6.  Relationship between spinal mobility measures and quality of life in patients with ankylosing spondylitis.

Authors:  Vladislava Vesović-Potić; Dusan Mustur; Dejana Stanisavljević; Tatjana Ille; Mihailo Ille
Journal:  Rheumatol Int       Date:  2009-01-27       Impact factor: 2.631

7.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

8.  Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.

Authors:  Martina Karpitschka; Patrizia Godau-Kellner; Herbert Kellner; Annie Horng; Daniel Theisen; Christian Glaser; Bernhard Brandlhuber; Maximilian Reiser; Sabine Weckbach
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

9.  A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations.

Authors:  Filip Van den Bosch
Journal:  Clin Rheumatol       Date:  2009-12-03       Impact factor: 2.980

10.  Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East.

Authors:  Bahiri Rachid; Bassel El Zorkany; Ehab Youseif; Mohammed Tikly
Journal:  Clin Rheumatol       Date:  2012-08-19       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.